Stanley Schwartz

Summary

Affiliation: University of Pennsylvania
Country: USA

Publications

  1. pmc Pioglitazone for the treatment of type 2 diabetes in patients inadequately controlled on insulin
    Stanley S Schwartz
    Diabetes Disease Management at the University of Pennsylvania, Penn Presbyterian Medical Center, Philadelphia Heart Institute, Philadelphia, Pennsylvania, USA
    Diabetes Metab Syndr Obes 3:243-52. 2010
  2. pmc Type 2 diabetes mellitus and the cardiometabolic syndrome: impact of incretin-based therapies
    Stanley Schwartz
    Department of Endocrinology, Diabetes, and Metabolism, University of Pennsylvania, Philadelphia, Pennsylvania, USA
    Diabetes Metab Syndr Obes 3:227-42. 2010
  3. ncbi request reprint Targeting the pathophysiology of type 2 diabetes: rationale for combination therapy with pioglitazone and exenatide
    Stanley Schwartz
    University of Pennsylvania, Philadelphia, PA, USA
    Curr Med Res Opin 24:3009-22. 2008
  4. pmc Association of lower plasma fetuin-a levels with peripheral arterial disease in type 2 diabetes
    Luis H Eraso
    Cardiovascular Institute, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    Diabetes Care 33:408-10. 2010
  5. pmc One-year weight losses in the Look AHEAD study: factors associated with success
    Thomas A Wadden
    Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    Obesity (Silver Spring) 17:713-22. 2009
  6. ncbi request reprint Safety and efficacy of s-citalopram in patients with co-morbid major depression and diabetes mellitus
    Jay D Amsterdam
    Depression Research Unit, Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA 19104 3309, USA
    Neuropsychobiology 54:208-14. 2006
  7. ncbi request reprint Can atorvastatin improve the response to sildenafil in men with erectile dysfunction not initially responsive to sildenafil? Hypothesis and pilot trial results
    Howard C Herrmann
    Hospital of the University of Pennsylvania, Philadelphia, 19104, USA
    J Sex Med 3:303-8. 2006
  8. pmc Usefulness of insulin resistance estimation and the metabolic syndrome in predicting coronary atherosclerosis in type 2 diabetes mellitus
    Nehal N Mehta
    Cardiovascular Institute, Philadelphia, Pennsylvania, USA
    Am J Cardiol 107:406-11. 2011
  9. doi request reprint How to manage perioperative endocrine insufficiency
    Benjamin A Kohl
    Department of Anesthesiology and Critical Care, University of Pennsylvania School of Medicine, 3400 Spruce Street, Dulles Building, Suite 680, Philadelphia, PA 19104, USA
    Anesthesiol Clin 28:139-55. 2010
  10. pmc Apolipoprotein B but not LDL cholesterol is associated with coronary artery calcification in type 2 diabetic whites
    Seth S Martin
    Cardiovascular Institute, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    Diabetes 58:1887-92. 2009

Detail Information

Publications14

  1. pmc Pioglitazone for the treatment of type 2 diabetes in patients inadequately controlled on insulin
    Stanley S Schwartz
    Diabetes Disease Management at the University of Pennsylvania, Penn Presbyterian Medical Center, Philadelphia Heart Institute, Philadelphia, Pennsylvania, USA
    Diabetes Metab Syndr Obes 3:243-52. 2010
    ..Thiazolidinediones represent an effective tool for targeting some features of this increased risk as they decrease insulin resistance and can prevent and/or delay diabetes progression...
  2. pmc Type 2 diabetes mellitus and the cardiometabolic syndrome: impact of incretin-based therapies
    Stanley Schwartz
    Department of Endocrinology, Diabetes, and Metabolism, University of Pennsylvania, Philadelphia, Pennsylvania, USA
    Diabetes Metab Syndr Obes 3:227-42. 2010
    ....
  3. ncbi request reprint Targeting the pathophysiology of type 2 diabetes: rationale for combination therapy with pioglitazone and exenatide
    Stanley Schwartz
    University of Pennsylvania, Philadelphia, PA, USA
    Curr Med Res Opin 24:3009-22. 2008
    ....
  4. pmc Association of lower plasma fetuin-a levels with peripheral arterial disease in type 2 diabetes
    Luis H Eraso
    Cardiovascular Institute, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    Diabetes Care 33:408-10. 2010
    ..Fetuin-A is an inhibitor of vascular calcification and a mediator of insulin resistance. This study evaluated the association of plasma fetuin-A and peripheral arterial disease (PAD)...
  5. pmc One-year weight losses in the Look AHEAD study: factors associated with success
    Thomas A Wadden
    Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    Obesity (Silver Spring) 17:713-22. 2009
    ..The lifestyle intervention was clinically effective in all subsets of an ethnically and demographically diverse population...
  6. ncbi request reprint Safety and efficacy of s-citalopram in patients with co-morbid major depression and diabetes mellitus
    Jay D Amsterdam
    Depression Research Unit, Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA 19104 3309, USA
    Neuropsychobiology 54:208-14. 2006
    ..We examined the safety and efficacy of s-citalopram therapy in patients with co-morbid depression and diabetes, and its ability to improve glycemic control...
  7. ncbi request reprint Can atorvastatin improve the response to sildenafil in men with erectile dysfunction not initially responsive to sildenafil? Hypothesis and pilot trial results
    Howard C Herrmann
    Hospital of the University of Pennsylvania, Philadelphia, 19104, USA
    J Sex Med 3:303-8. 2006
    ..Erectile dysfunction (ED) may be one manifestation of a generalized vascular disorder characterized by endothelial dysfunction. Statin drugs may improve endothelial function, even before altering the lipid profile...
  8. pmc Usefulness of insulin resistance estimation and the metabolic syndrome in predicting coronary atherosclerosis in type 2 diabetes mellitus
    Nehal N Mehta
    Cardiovascular Institute, Philadelphia, Pennsylvania, USA
    Am J Cardiol 107:406-11. 2011
    ....
  9. doi request reprint How to manage perioperative endocrine insufficiency
    Benjamin A Kohl
    Department of Anesthesiology and Critical Care, University of Pennsylvania School of Medicine, 3400 Spruce Street, Dulles Building, Suite 680, Philadelphia, PA 19104, USA
    Anesthesiol Clin 28:139-55. 2010
    ..This article focuses on the 4 most commonly encountered endocrinopathies: diabetes mellitus, hyperthyroidism, hypothyroidism, and adrenal insufficiency. Specific challenges pertaining to patients with pheochromocytoma are also discussed...
  10. pmc Apolipoprotein B but not LDL cholesterol is associated with coronary artery calcification in type 2 diabetic whites
    Seth S Martin
    Cardiovascular Institute, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    Diabetes 58:1887-92. 2009
    ..We investigated the hypothesis that apoB is a superior marker of CAC relative to LDL cholesterol...
  11. doi request reprint Surgery in the patient with endocrine dysfunction
    Benjamin A Kohl
    Department of Anesthesiology and Critical Care, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    Med Clin North Am 93:1031-47. 2009
    ..This article focuses on 4 of the most common endocrinopathies: diabetes mellitus, hyperthyroidism, hypothyroidism, and adrenal insufficiency. Perioperative challenges in patients presenting with pheochromocytoma are also discussed...
  12. pmc Is incretin-based therapy ready for the care of hospitalized patients with type 2 diabetes?: The time has come for GLP-1 receptor agonists!
    Stanley Schwartz
    Main Line Health System, University of Pennsylvania, Philadelphia, Pennsylvania, USA
    Diabetes Care 36:2107-11. 2013
    ..Schwartz and DeFronzo's contribution, Drs. Umpierrez and Korytkowski provide a defense of insulin in the inpatient setting as the unquestioned gold standard for glycemic management in hospitalized settings...
  13. doi request reprint The use of non-insulin anti-diabetic agents to improve glycemia without hypoglycemia in the hospital setting: focus on incretins
    Stanley Schwartz
    Main Line Health System, University of Pennsylvania, Philadelphia, PA, USA
    Curr Diab Rep 14:466. 2014
    ..We strongly urge randomized prospective controlled studies to test our proposal and we offer a process of care to facilitate this research and their use in our hospitalized patients...
  14. doi request reprint Can the genetics of type 1 and type 2 diabetes shed light on the genetics of latent autoimmune diabetes in adults?
    Struan F A Grant
    Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    Endocr Rev 31:183-93. 2010
    ..In this review, we address recent advances in the genetics of T1D and T2D and how such discoveries have in turn shed some light on the genetics of LADA as being potentially at the "genetic intersection" of these two major diseases...